一种利用Medicare医保索赔评估ADRD老年患者效应修饰的新型工具
A Novel Tool for Evaluating Effect Modification in Older Adults with ADRD Using Medicare Claims
浏览论文内容
中文总结 AI 辅助
本研究针对ADRD老年患者，提出PD-Robust分析策略，利用Medicare数据揭示HAC效应异质性，验证其在真实世界研究中的良好性能。
中文摘要 AI 辅助
研究基线暴露后的结局对于利用真实世界数据推进比较有效性研究愈发重要。本案例研究评估了髋部骨折住院期间的医院获得性状况（HAC）对阿尔茨海默病及相关痴呆（ADRD）老年患者出院后恢复轨迹的影响，该人群尤其易出现出院后高死亡率。为恰当考虑死亡导致的恢复轨迹截断，并探索患者人口统计学特征对效应修饰的异质性，我们提出了一种新型伪数据驱动的稳健（PD-Robust）分析策略，附带R包及详细使用指南，为真实数据分析提供参考。PD-Robust基于主可忽略性下的主分层及结构工作模型，通过可解释的估计量实现，可应对死亡导致的截断，提供模型诊断与假设违反的稳健性检验，并有助于刻画主分层中的患者特征。将其应用于Medicare医保索赔数据时，出院后6个月内居家天数（DAH）越多代表恢复越好，PD-Robust揭示了HAC效应的异质性：85岁以下男性高危亚组在HAC与无HAC相比，DAH减少多达23天，超过了任何暴露导致DAH具有临床意义差异的8天阈值。此外，模拟研究进一步表明，PD-Robust估计偏差低且统计推断准确，支持其在真实世界数据应用中的实用性。
英文摘要
Studying consequences following baseline exposures has become increasingly important for advancing comparative effectiveness research using real-world data. This case study evaluates the impact of hospital-acquired conditions (HAC) during hospitalization for hip fracture on post-discharge recovery trajectories among older adults living with Alzheimer Disease and Related Dementia, a population particularly vulnerable to high post-hospital mortality. To appropriately account for truncation of recovery trajectory due to death and to explore heterogeneity in effect modification by patient demographics, we introduce a novel pseudo data-based robust (PD-Robust) analysis strategy, accompanied by an R package and detailed usage guidance to inform real data analysis. Grounded in an interpretable estimand via principal stratification under principal ignorability and a structural working model, PD-Robust accommodates truncation by death, provides model diagnosis and robustness check against assumption violation, and facilitates the characterization of patient profiles among the principal stratum. Applied to Medicare claims data, where better recovery is defined as more days at home (DAH) over six months post-discharge, PD-Robust reveals heterogeneity in HAC effects, with males under the age of 85 years as a high-risk subgroup experiencing up to 23 fewer DAH, comparing HAC to no HAC. This exceeds the 8-day threshold regarded as clinically meaningful difference in DAH due to any exposure. Moreover, simulation studies further demonstrate that PD-Robust achieves low estimation bias and accurate statistical inference, supporting its utility in real-world data applications.
